Should FDG PET be used to Decide Whether a Patient with an Abnormal Mammogram or Breast Finding at Physical Examination should Undergo Biopsy?
- 1 July 2002
- journal article
- research article
- Published by Elsevier in Academic Radiology
- Vol. 9 (7) , 773-783
- https://doi.org/10.1016/s1076-6332(03)80347-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging proceduresEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and LimitationsJournal of Clinical Oncology, 2000
- New directions in breast biopsy: Review of current minimally invasive methods and presentation of a new coaxial techniqueSeminars in Ultrasound, CT and MRI, 2000
- Positron Emission Mammographic Instrument: Initial ResultsRadiology, 2000
- Comparison of FDG-PET with MIBI-SPECT in the Detection of Breast Cancer and Axillary Lymph Node MetastasisJournal of Computer Assisted Tomography, 2000
- Positron emission tomography in breast cancer: a clinicopathological correlation of results.The British Journal of Radiology, 1999
- Positive predictive value of the breast imaging reporting and data system11No competing interests declared.Journal of the American College of Surgeons, 1999
- The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories.American Journal of Roentgenology, 1998
- Guidelines for Meta-analyses Evaluating Diagnostic TestsAnnals of Internal Medicine, 1994
- The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions.American Journal of Roentgenology, 1991